ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$TXG:NASDAQ · 10X GENOMICS INC

Sector: health

Conviction from: NASDAQ

52-week range: 15.18102.81

10x Genomics develops instruments, consumables, and software for single-cell and spatial biology, enabling researchers to analyze gene expression and tissue at the cellular level.

3 tracked filer(s) hold this · 1 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s) · buyers (new/add) avg 58. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy2,500$225,9000.0%
Bridgewater55Added +771%116,482$10,525,3140.0%
Steve Cohen / Point7275Trimmed -96%74,611$6,741,8500.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#135 — State of the Themes: The End of the Trade (As We Know It)2026-11-04WATCH
#134 — Citrini Therapeutics: We Wanted to Use Claude to Create a New Drug2026-10-20WATCH
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28WATCH
#92 — Market Memo: Talk to Me, Goose2025-04-13SHORT

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.